123 related articles for article (PubMed ID: 26132494)
1. Frequency and characteristics of circulating CD4(+) CD28(null) T cells in patients with psoriasis.
Lima XT; Cintra ML; Piaza AC; Mamoni RL; Oliveira RT; Magalhães RF; Blotta MH
Br J Dermatol; 2015 Oct; 173(4):998-1005. PubMed ID: 26132494
[TBL] [Abstract][Full Text] [Related]
2. Characterization of CD4+CD28null T cells in patients with coronary artery disease and individuals with risk factors for atherosclerosis.
Téo FH; de Oliveira RT; Mamoni RL; Ferreira MC; Nadruz W; Coelho OR; Fernandes Jde L; Blotta MH
Cell Immunol; 2013 Jan; 281(1):11-9. PubMed ID: 23416719
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic CD4+CD28 null T lymphocytes, systemic inflammation and atherosclerotic risk in patients with chronic kidney disease.
Yadav AK; Lal A; Jha V
Nephron Clin Pract; 2012; 120(4):c185-93. PubMed ID: 22907478
[TBL] [Abstract][Full Text] [Related]
4. CD4+CD28null cells are expanded and exhibit a cytolytic profile in end-stage renal disease patients on peritoneal dialysis.
Yadav AK; Jha V
Nephrol Dial Transplant; 2011 May; 26(5):1689-94. PubMed ID: 21382991
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of circulating CD4+CD28null T cells is associated with early atherosclerotic damage in patients with end-stage renal disease undergoing hemodialysis.
Sun Z; Ye H; Tang B; Shen X; Wu X; Zhong H; Song W
Hum Immunol; 2013 Jan; 74(1):6-13. PubMed ID: 22902395
[TBL] [Abstract][Full Text] [Related]
6. CD4⁺CD28null T lymphocytes resemble CD8⁺CD28null T lymphocytes in their responses to IL-15 and IL-21 in HIV-infected patients.
Echeverría A; Moro-García MA; Asensi V; Cartón JA; López-Larrea C; Alonso-Arias R
J Leukoc Biol; 2015 Sep; 98(3):373-84. PubMed ID: 26034206
[TBL] [Abstract][Full Text] [Related]
7. Expansion of CD4+CD28null T-lymphocytes in diabetic patients: exploring new pathogenetic mechanisms of increased cardiovascular risk in diabetes mellitus.
Giubilato S; Liuzzo G; Brugaletta S; Pitocco D; Graziani F; Smaldone C; Montone RA; Pazzano V; Pedicino D; Biasucci LM; Ghirlanda G; Crea F
Eur Heart J; 2011 May; 32(10):1214-26. PubMed ID: 21217142
[TBL] [Abstract][Full Text] [Related]
8. High levels of costimulatory receptors OX40 and 4-1BB characterize CD4+CD28null T cells in patients with acute coronary syndrome.
Dumitriu IE; Baruah P; Finlayson CJ; Loftus IM; Antunes RF; Lim P; Bunce N; Kaski JC
Circ Res; 2012 Mar; 110(6):857-69. PubMed ID: 22282196
[TBL] [Abstract][Full Text] [Related]
9. IL-15 preferentially enhances functional properties and antigen-specific responses of CD4+CD28(null) compared to CD4+CD28+ T cells.
Alonso-Arias R; Moro-García MA; Vidal-Castiñeira JR; Solano-Jaurrieta JJ; Suárez-García FM; Coto E; López-Larrea C
Aging Cell; 2011 Oct; 10(5):844-52. PubMed ID: 21635686
[TBL] [Abstract][Full Text] [Related]
10. Characterization and clinical relevance of circulating CD4+CD28- T cells in Graves' disease.
Wang F; Chen L; Shen Q; Liu T; Jiang L; Gu X; Chen L; Sun J; Liu C
Immunol Lett; 2015 May; 165(1):47-51. PubMed ID: 25839128
[TBL] [Abstract][Full Text] [Related]
11. CX(3)CR1 drives cytotoxic CD4(+)CD28(-) T cells into the brain of multiple sclerosis patients.
Broux B; Pannemans K; Zhang X; Markovic-Plese S; Broekmans T; Eijnde BO; Van Wijmeersch B; Somers V; Geusens P; van der Pol S; van Horssen J; Stinissen P; Hellings N
J Autoimmun; 2012 Feb; 38(1):10-9. PubMed ID: 22123179
[TBL] [Abstract][Full Text] [Related]
12. CD4+ CD28(null) cells are an independent predictor of mortality in patients with heart failure.
Koller L; Richter B; Goliasch G; Blum S; Korpak M; Zorn G; Brekalo M; Maurer G; Wojta J; Pacher R; Hülsmann M; Niessner A
Atherosclerosis; 2013 Oct; 230(2):414-6. PubMed ID: 24075776
[TBL] [Abstract][Full Text] [Related]
13. Senescent profile of angiogenic T cells from systemic lupus erythematosus patients.
López P; Rodríguez-Carrio J; Martínez-Zapico A; Caminal-Montero L; Suarez A
J Leukoc Biol; 2016 Mar; 99(3):405-12. PubMed ID: 26232454
[TBL] [Abstract][Full Text] [Related]
14. T cell infiltrates in the muscles of patients with dermatomyositis and polymyositis are dominated by CD28null T cells.
Fasth AE; Dastmalchi M; Rahbar A; Salomonsson S; Pandya JM; Lindroos E; Nennesmo I; Malmberg KJ; Söderberg-Nauclér C; Trollmo C; Lundberg IE; Malmström V
J Immunol; 2009 Oct; 183(7):4792-9. PubMed ID: 19752224
[TBL] [Abstract][Full Text] [Related]
15. Heat shock proteins 60 and 70 specific proinflammatory and cytotoxic response of CD4+CD28null cells in chronic kidney disease.
Yadav AK; Kumar V; Jha V
Mediators Inflamm; 2013; 2013():384807. PubMed ID: 24347824
[TBL] [Abstract][Full Text] [Related]
16. Expression of CD4
El-Samahy MH; Tantawy AAG; Adly AAM; Habeeb NM; Ismail EAR; Hamed GM; Eladawy R
Pediatr Diabetes; 2017 Dec; 18(8):785-793. PubMed ID: 28102614
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of CD28 and CTLA-4 expression by CD4 T cells from previously immunodeficient HIV-infected patients with sustained virological responses to highly active antiretroviral therapy.
Stone SF; Price P; French MA
HIV Med; 2005 Jul; 6(4):278-83. PubMed ID: 16011533
[TBL] [Abstract][Full Text] [Related]
18. Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares.
Amoura Z; Combadiere C; Faure S; Parizot C; Miyara M; Raphaël D; Ghillani P; Debre P; Piette JC; Gorochov G
Arthritis Rheum; 2003 Dec; 48(12):3487-96. PubMed ID: 14673999
[TBL] [Abstract][Full Text] [Related]
19. Circulating levels of chemokines in psoriasis.
Lima XT; Oliveira RT; Braga FG; Magalhães RF; Mamoni RL; Blotta MH
Autoimmunity; 2015 Feb; 48(1):57-60. PubMed ID: 25117898
[TBL] [Abstract][Full Text] [Related]
20. CD4+ and CD8+ CD28(null) T Cells Are Cytotoxic to Autologous Muscle Cells in Patients With Polymyositis.
Pandya JM; Venalis P; Al-Khalili L; Shahadat Hossain M; Stache V; Lundberg IE; Malmström V; Fasth AE
Arthritis Rheumatol; 2016 Aug; 68(8):2016-26. PubMed ID: 26895511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
